Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
Bio-Rad Labs (BIO) Tops Q3 EPS by 11c
November 1, 2016 5:15 PM EDTBio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.62, $0.11 better than the analyst estimate of $0.51. Revenue for the quarter came in at $508.7 million versus the consensus estimate of $480.6 million.
"We are pleased with a strong sales performance in the third quarter, in particular, our life science... More

